| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A CASE OF FASCIOLOSIS PRESENTING WITH SEVERE HYPEREOSINOPHILIA
|
Mastanzade, Metban
|
|
|
44 |
S1 |
p. S35
|
artikel
|
| 2 |
ALECTINIB-RELATED ERYTHROCYTE MEMBRANE CHANGES, NON-IMMUNE HEMOLYSIS AND ERYPTOSIS
|
Gulturk, Emine
|
|
|
44 |
S1 |
p. S37
|
artikel
|
| 3 |
ANTIBODY RESPONSES AND SAFETY OF THE COMMERCIALLY AVAILABLE VACCINES AGAINST SARS-COV-2 VIRUS IN ALLOGRAFTED PATIENTS: REAL WORLD DATA FROM A SINGLE CENTER
|
Kaloyannidis, Panayotis
|
|
|
44 |
S1 |
p. S17-S18
|
artikel
|
| 4 |
AN UNUSUAL OCULAR LYMPHOMA, PRIMARY INTRAVITREAL LYMPHOMA DIAGNOSED INCIDENTALLY
|
Ibili Cetinkaya, Nur Seda
|
|
|
44 |
S1 |
p. S30-S31
|
artikel
|
| 5 |
AN UPDATED OF PIONEER PROJECT TO COLLECT DATA OF T-CELL NHL PATIENTS AMONG FIVE REGIONS OF BRAZIL. T-CELL BRAZIL PROJECT
|
De SOUZA, Carmino A
|
|
|
44 |
S1 |
p. S14-S15
|
artikel
|
| 6 |
Appropriate management of Polycythemia Vera with cytoreductive drug therapy
|
BARBUI, Tiziano
|
|
|
44 |
S1 |
p. S3-S4
|
artikel
|
| 7 |
A RARE PRESENTATION OF SYSTEMIC AL AMYLOIDOSIS; PULMONARY AL AMYLOIDOSIS
|
ERDEM, Simge
|
|
|
44 |
S1 |
p. S19
|
artikel
|
| 8 |
ASSOCIATION OF NF-1 AND MOYAMOYA SYNDROME : CASE REPORT
|
Karaman, Serap
|
|
|
44 |
S1 |
p. S43
|
artikel
|
| 9 |
Brentuximab Vedotin versus checkpoint inhibitors: Which one? When? Why should be preferred?
|
Özbalak, Murat
|
|
|
44 |
S1 |
p. S1-S2
|
artikel
|
| 10 |
CART CELL THERAPY BLACK SHADOW IN HEMATOLOGICAL DISORDERS : SYSTEMIC REVIEW WITH META-ANALYSIS
|
Gohary, Ghada EL
|
|
|
44 |
S1 |
p. S34-S35
|
artikel
|
| 11 |
Comparison of the quality of life of patients with a beta-thalassemia major, regularly receiving parenteral and oral chelators
|
Hasanova, Samira
|
|
|
44 |
S1 |
p. S23
|
artikel
|
| 12 |
CORONAVIRUS ANXIETY LEVEL AND COVID 19 VACCINE ATTITUDE AMONG HEMATOLOGICAL MALIGNANCY PATIENTS
|
GÜVEN, Zeynep Tuğba
|
|
|
44 |
S1 |
p. S18-S19
|
artikel
|
| 13 |
EARLY T-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDHOOD
|
Ören, Hale
|
|
|
44 |
S1 |
p. S10-S11
|
artikel
|
| 14 |
ECULIZUMAB DOSE ADJUSTMENTS DURING PREGNANCIES IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: A SINGLE CENTER EXPERIENCE.
|
Aydin, Semra
|
|
|
44 |
S1 |
p. S37
|
artikel
|
| 15 |
EFFICACY OF FUROSEMIDE IN METHOTREXATE CLEARANCE IN PATIENTS TREATED WITH HIGH DOSE METHOTREXATE
|
Khan, Saqib
|
|
|
44 |
S1 |
p. S34
|
artikel
|
| 16 |
EMERGING DATA FOR CANCER ASSOCIATED THROMBOSIS TREATMENT
|
Sivera, Piera
|
|
|
44 |
S1 |
p. S6
|
artikel
|
| 17 |
EVALUATION AND MANAGEMENT OF THYROID NODULES AT A TERTIARY CARE PEDIATRIC CANCER CENTER IN TURKEY
|
Şahin, Seda
|
|
|
44 |
S1 |
p. S43-S44
|
artikel
|
| 18 |
EVALUATION OF CLINICAL AND LABORATORY FINDINGS OF THERAPEUTIC PLASMAPHERESIS IN CHILDREN
|
Tutun, Buğra
|
|
|
44 |
S1 |
p. S41-S42
|
artikel
|
| 19 |
EVALUATION OF COVID-19 FEAR AND QUALITY OF LIFE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION DURING THE COVID-19 PANDEMIC
|
Çelik, Serhat
|
|
|
44 |
S1 |
p. S16
|
artikel
|
| 20 |
Evaluation of Microbiologically Documented Bloodstream Infections in Pediatric Hematology/Oncology Patients: Results of Ten Years
|
İŞERİ KÜSKÜ, Zehra Aslı
|
|
|
44 |
S1 |
p. S25-S26
|
artikel
|
| 21 |
Evaluation of MRD-status in post-induction period in pediatric patients with acute lymphoblastic leukemia.
|
Shervashidze, Meri
|
|
|
44 |
S1 |
p. S22
|
artikel
|
| 22 |
Follow-up of Chronic Myeloid Leukemia Patients whose Tyrosine Kinase Treatment Was Stopped: Case Series
|
Fidan, Kemal
|
|
|
44 |
S1 |
p. S27-S28
|
artikel
|
| 23 |
FROM ALLOGENIC TRANSPLANTATION TO PRECISION IMMUNE THERAPY
|
Rossi, Jean-François
|
|
|
44 |
S1 |
p. S8
|
artikel
|
| 24 |
Ghosal hematodiaphyseal dysplasia (GHDD) diagnosis and treatment: case report
|
MAMMADOVA, Gular
|
|
|
44 |
S1 |
p. S22-S23
|
artikel
|
| 25 |
GLOMERULAR MICROANGIOPATHY WITH MARKED SYSTEMIC THROMBOTIC MICROANGIOPATHY SHORTLY AFTER BORTEZOMIB IN A NEWLY DIAGNOSED POEMS SYNDROME PATIENT
|
Tiryaki, Tarık Onur
|
|
|
44 |
S1 |
p. S38
|
artikel
|
| 26 |
GRISCELLI SYNDROME TYPE 2 –CLINICAL APPROACH AND CASE REPORT
|
Baghirova, Konul
|
|
|
44 |
S1 |
p. S39
|
artikel
|
| 27 |
HBH DISEASE AND SYSTEMIC LUPUS ERYTHEMATOSUS
|
Huseynov, Valeh
|
|
|
44 |
S1 |
p. S41
|
artikel
|
| 28 |
HOW I TREAT DOUBLE-HIT LYMPHMOMA AND HGBL, NOS
|
Duffles, Guilherme
|
|
|
44 |
S1 |
p. S3
|
artikel
|
| 29 |
How we (will) treat PNH?
|
AYDIN, Semra
|
|
|
44 |
S1 |
p. S7
|
artikel
|
| 30 |
HUMORAL IMMUNITY RESPONSES AFTER VACCINATION FOR HEPATITIS B VIRUS IN AUTOGRAFTED PATIENTS: A SINGLE CENTER EXPERIENCE
|
Kaloyannidis, Panayotis
|
|
|
44 |
S1 |
p. S17
|
artikel
|
| 31 |
Immunophenotypic features of molecular subtypes of breast cancer
|
Chulkova, S.V.
|
|
|
44 |
S1 |
p. S20-S21
|
artikel
|
| 32 |
IMPACT OF COVID-19 PANDEMIC ON DELAY OF CHILDHOOD CANCER DIAGNOSIS AND THE OUTCOMES IN A PEDIATRIC HEMATOLOGY/ONCOLOGY DEPARTMENT
|
CAKMAKCI, Selma
|
|
|
44 |
S1 |
p. S24
|
artikel
|
| 33 |
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA – CHALLENGING ISSUES OF HEMATO-ONCOLOGY
|
Musteata, Vasile
|
|
|
44 |
S1 |
p. S21
|
artikel
|
| 34 |
INFLUENCE OF CANCER NEWS ON QUALITY OF LIFE OF PATIENT'S FAMILIES: AN OBSERVATIONAL STUDY
|
Khan, Saqib
|
|
|
44 |
S1 |
p. S26
|
artikel
|
| 35 |
INTRAPLEURAL THERAPY TO DISRUPT IL-6/IL-8 JUXTACTINE SIGNALLING TO BLOCK TUMOR EMT AND TO DRIVE SYSTEMIC ANTI-TUMOR IMMUNITY
|
Donnenberg, Vera
|
|
|
44 |
S1 |
p. S24-S25
|
artikel
|
| 36 |
Is there any new prognostic score for peripheral T-cell lymphoma?
|
Akkurd, D.M.
|
|
|
44 |
S1 |
p. S32-S33
|
artikel
|
| 37 |
LABORATORY AND CLINICAL FEATURES OF TUMOR LYSIS SYNDROME IN CHILDREN WITH HIGH-GRADE NON-HODGKIN LYMPHOMA AND EVALUATION LONG-TERM RENAL FUNCTIONS IN SURVIVORS
|
BOZKURT, Selcen
|
|
|
44 |
S1 |
p. S23-S24
|
artikel
|
| 38 |
Lessons from the European and Israel National MDS Registry
|
Stemer, Galia
|
|
|
44 |
S1 |
p. S5-S6
|
artikel
|
| 39 |
LONG-TERM OUTCOMES OF PATIENTS TREATED WITH CAPLACIZUMAB FOR IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP): THE POST-HERCULES STUDY
|
Pektaş, Özgür
|
|
|
44 |
S1 |
p. S33-S34
|
artikel
|
| 40 |
Low Incidence of Central Nervous System (CNS) Relapse of Diffuse Large B-Cell Lymphoma despite Limited Use of Intrathecal Prophylaxis
|
Aleem, Aamer
|
|
|
44 |
S1 |
p. S13-S14
|
artikel
|
| 41 |
Molecular Aspects in Chronic Lymphocytic Leukemia patients with Autoimmune Cytopenias: single center experience
|
Trajkova, Sanja
|
|
|
44 |
S1 |
p. S27
|
artikel
|
| 42 |
MRD IN BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM
|
Palladina, Aleksandra
|
|
|
44 |
S1 |
p. S25
|
artikel
|
| 43 |
NIVOLUMAB EXPERIENCE IN PEDIATRIC MALIGNITIES
|
ORTAKOYLU, Melek YAMAN
|
|
|
44 |
S1 |
p. S25
|
artikel
|
| 44 |
NON-HODGKIN'S LYMPHOMA: A RETROSPECTIVE ASSESSMENT OF CLINICAL FEATURES AND TREATMENT OUTCOMES
|
Tutun, Zeynep Deniz
|
|
|
44 |
S1 |
p. S42
|
artikel
|
| 45 |
Pediatric Acute Myeloid Leukemia (AML): NOTCH1 activation influencing prognosis through Transforming Growth Factor-B (TGF-Beta) / SETBP1; Report of a Pilot Study from Saudi Arabia
|
ELYAMANY, GHALEB
|
|
|
44 |
S1 |
p. S15-S16
|
artikel
|
| 46 |
PHENOTYPE/ GENOTYPE SCREENING PATTERN OF HEMOPHILIA A AND B IN SAUDI ARAB
|
Owaidah, Tarek
|
|
|
44 |
S1 |
p. S28-S29
|
artikel
|
| 47 |
PREVENTION CAN BE THE BEST TOOL FOR ADULT T-CELL LEUKEMIA. UPDATED T-CELL BRAZIL PROJECT
|
De Sousa, Carmino
|
|
|
44 |
S1 |
p. S30
|
artikel
|
| 48 |
QUALITY OF LIFE IN HEMATOLOGICAL PATIENTS IN THE POST-COVID ERA
|
Lebowa, Weronika
|
|
|
44 |
S1 |
p. S36-S37
|
artikel
|
| 49 |
RARE UNSTABLE ALPHA GLOBIN VARIANT HB TAYBE (HBA1:C.118_120DELACC) WITH HBA2 POLY A MUTATIONS, CAUSES TO HEMOLYTIC ANEMIA IN TWO CASES FROM AZERBAIJAN
|
Aghayev, AghaRza
|
|
|
44 |
S1 |
p. S40-S41
|
artikel
|
| 50 |
REAL-LIFE STUDY OF BIO-CLINICAL FOLLOW-UP AFTER BNT162b2 mRNA COVID-19 (BNTCV) VACCINATION IN 235 PATIENTS (PTS) INCLUDING 225 WITH HEMATOLOGICAL MALIGNANCIES (HM).
|
Rossi, Jean-François
|
|
|
44 |
S1 |
p. S19-S20
|
artikel
|
| 51 |
RECTAL CANCER DISTANCE TO THE ANAL VERGE AND THE T STAGING: MAGNETIC RESONANCE IMAGING FINDINGS
|
Omar, Abdalraouf
|
|
|
44 |
S1 |
p. S35
|
artikel
|
| 52 |
Reduced Intensity Conditioning for Allogeneic Stem Cell Transplantation (HSCT) in Acute Myeloid Leukemia
|
Nagler, Arnon
|
|
|
44 |
S1 |
p. S5
|
artikel
|
| 53 |
RELAPSED MANTLE CELL LYMPHOMA WITH ISOLATED CENTRAL NERVOUS SYSTEM INVOLVEMENT THAT TREATED WITH IBRUTINIB; A CASE REPORT AND LITERATURE REVIEW
|
Tiglioglu, Pinar
|
|
|
44 |
S1 |
p. S32
|
artikel
|
| 54 |
Risk assessment for newly diagnosed, fit and young patients with Multiple Myeloma, in the era of novel treatment modalities: Are there any additional factors to be under consideration?
|
Kaloyannidis, Panayotis
|
|
|
44 |
S1 |
p. S33
|
artikel
|
| 55 |
RITUXIMAB INDUCED LUNG DISEASE IN A MANTLE CELL LYMPHOMA PATIENT RECEIVING MAINTENANCE: CASE PRESENTATION
|
Öztürkmen, Aslı
|
|
|
44 |
S1 |
p. S31
|
artikel
|
| 56 |
RITUXIMAB-INDUCED SEVERE ACUTE THROMBOCYTOPENIA IN A PATIENT WITH SPLENIC MARGINAL ZONE LYMPHOMA
|
Kars, Taha Ulutan
|
|
|
44 |
S1 |
p. S35-S36
|
artikel
|
| 57 |
ROLE OF SERUM HEPCIDIN AND RETICULOCYTE HEMOGLOBIN CONCENTRATION IN EVALUATION OF ANEMIA IN ULCERATIVE COLITIS PATIENTS
|
Gawaly, Amr Mohamed Gawaly
|
|
|
44 |
S1 |
p. S39
|
artikel
|
| 58 |
SERUM LEVEL OF VASCULAR CELL ADHESION MOLECULE AND P SELECTIN AS THROMBOPHILIC RISK FACTOR FOR EARLY VASCULAR ACCESS THROMBOTIC OCCLUSION IN HEMODIALYSIS PATIENTS
|
Sherif, Mohamed
|
|
|
44 |
S1 |
p. S29
|
artikel
|
| 59 |
SERUM TOTAL OXIDANT AND ANTIOXIDANT STATUS IN CHILDREN WITH CANCER
|
Yilmaz, Yasin
|
|
|
44 |
S1 |
p. S44
|
artikel
|
| 60 |
STEM CELL TRANSPLANTATION IN BRAIN TUMORS
|
Hazar, Volkan
|
|
|
44 |
S1 |
p. S11
|
artikel
|
| 61 |
SUBCUTANEOUS TREATMENT MODALITIES IN HEMOPHILIA CARE IN 2022
|
Noun, Peter
|
|
|
44 |
S1 |
p. S11
|
artikel
|
| 62 |
SUCCESSFUL MANAGEMENT OF SEVERE CONGENITAL FACTOR X DEFICIENCY DURING PREGNANCY AND LABOR WITH PCC IN TWO SISTERS
|
Haroon, Alfadil
|
|
|
44 |
S1 |
p. S29-S30
|
artikel
|
| 63 |
SUCCINATE DEHYDROGENASE SUBUNIT B DEFICIENT PEDIATRIC GIST
|
Ortakoylu, Melek Yaman
|
|
|
44 |
S1 |
p. S42
|
artikel
|
| 64 |
SYNOVIAL SARCOMA ARISING IN THE RETROMOLAR TRIGONE: A RARE PRESENTATION
|
Saleem, Asma
|
|
|
44 |
S1 |
p. S43
|
artikel
|
| 65 |
THE ACUTE LYMPHOBLASTIC LEUKEMIA OF DOWN SYNDROME
|
SELIMOGLU, Cemile
|
|
|
44 |
S1 |
p. S13
|
artikel
|
| 66 |
THE COURSE OF TOXIC HEPATITIS IN LEUKEMIC PATIENTS AT THE STAGE OF SUPPORT THERAPY.
|
Babayev, Mireldar
|
|
|
44 |
S1 |
p. S39-S40
|
artikel
|
| 67 |
THE DIVERSITY OF PRESENTATION AND MANAGEMENT OF SUBCUTANEOUS PANNICULITIS –LIKE T-CELL LYMPHOMA WITH ASSOCIATED HEMOPHAGOCYTIC SYNDROME - CASE SERIES ANALYSIS
|
Giza, Agnieszka
|
|
|
44 |
S1 |
p. S32
|
artikel
|
| 68 |
THE EFFECT OF THE COVID-19 PANDEMIC PROCESS ON TREATMENT COMPLIANCE IN HEMOPHILIA PATIENTS
|
Şahin, Şifa
|
|
|
44 |
S1 |
p. S21-S22
|
artikel
|
| 69 |
THE MENTAL HEALTH STATUS OF INPATIENTS WITH NEWLY DIAGNOSED HEMATOLOGICAL CANCER DURING THE COVID-19 PANDEMIC
|
CAN, Ferda
|
|
|
44 |
S1 |
p. S18
|
artikel
|
| 70 |
THE RELATIONSHIP BETWEEN FERRITIN LEVEL AND THROMBOSIS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
|
Sağlam, Buğra
|
|
|
44 |
S1 |
p. S31
|
artikel
|
| 71 |
THE SUCCESSFUL MAJOR SURGERY IN A PATIENT WITH INHERITED FVII DEFICIENCY AND A HUGE NASOPHARYNGEAL ANGIOFIBROMA
|
Unuvar, Aysegul
|
|
|
44 |
S1 |
p. S38
|
artikel
|
| 72 |
The Then, Now, & Future of Engineered T-Cell Therapeutics for Human Application
|
Levine, Bruce
|
|
|
44 |
S1 |
p. S7-S8
|
artikel
|
| 73 |
TRAMETINIB EXPERIENCE IN A BRAF P.N 486 _P490DEL MUTATION POSITIVE LANGERHANS CELL HISTIOCYTOSIS
|
Gencel Karaaslan, Sevim
|
|
|
44 |
S1 |
p. S44
|
artikel
|
| 74 |
TREATMENT-FREE REMISSION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: MANAGEMENT APPROACHES
|
Musteata, Vasile
|
|
|
44 |
S1 |
p. S28
|
artikel
|
| 75 |
TREATMENT/MANAGEMENT OF OTHER HEPATIC TUMORS
|
Genc, Dildar Bahar
|
|
|
44 |
S1 |
p. S11-S12
|
artikel
|
| 76 |
TREATMENT OF A PATIENT DIAGNOSED WITH ERDHEIM CHESTER'S DISEASE IN COOPERATION WITH PLASTIC SURGERY AND HEMATOLOGY
|
ERDEM, Simge
|
|
|
44 |
S1 |
p. S19
|
artikel
|
| 77 |
Treatment of Mantle Cell Lymphoma in Transplant Non-Eligible Patients
|
Huseynov, Valeh
|
|
|
44 |
S1 |
p. S2-S3
|
artikel
|
| 78 |
TREATMENT OF SICKLE CELL ANEMIA
|
Alkindi, Dr. Salam
|
|
|
44 |
S1 |
p. S10
|
artikel
|
| 79 |
UMBILICAL CORD BLOOD (UCB) AND BONE MARROW (BM) AS A SOURCE OF NATURAL KILLERS (NK) FOR KIR-ALLOREACTIVE ADOPTIVE IMMUNOTHERAPY (KIR-AI)
|
Melkova, Kapitolina
|
|
|
44 |
S1 |
p. S16-S17
|
artikel
|
| 80 |
UPDATED PROGRESSION-FREE SURVIVAL (PFS) AND DEPTH OF RESPONSE IN IKEMA, A RANDOMIZED PHASE 3 TRIAL OF ISATUXIMAB, CARFILZOMIB AND DEXAMETHASONE (ISA-KD) VS KD IN RELAPSED MULTIPLE MYELOMA (MM)
|
PEKTAS, Ozgur
|
|
|
44 |
S1 |
p. S15
|
artikel
|
| 81 |
USA EXPERIENCE: IN-HOUSE PREPARATION: PROSPECTS AND PROBLEMS
|
Donnenberg, Albert
|
|
|
44 |
S1 |
p. S9
|
artikel
|
| 82 |
Vaccination Against SARS-CoV-2 for Myeloma Patients: Do We Need a Booster Dose and How Frequent?
|
Terpos, Evangelos
|
|
|
44 |
S1 |
p. S4-S5
|
artikel
|
| 83 |
Vascular Diseases in PNH
|
Hamed, Hanan
|
|
|
44 |
S1 |
p. S6-S7
|
artikel
|
| 84 |
VITAMIN B 12 DEFICIENCY MIMICKING THROMBOTIC MICROANGIOPATHY: A CASE REPORT
|
Aslaner Ak, Müzeyyen
|
|
|
44 |
S1 |
p. S36
|
artikel
|
| 85 |
Will immune therapy cure acute myeloid leukemia?
|
Gale, Robert Peter
|
|
|
44 |
S1 |
p. S1
|
artikel
|
| 86 |
XIII EHOC 2022 / CELLULAR THERAPY: CAR T-CELLS IN HEMATOLOGICAL MALIGNANCIES
|
|
|
|
44 |
S1 |
p. S8-S9
|
artikel
|
Tijdschrift beschrijving